Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$1.22 USD
-0.19 (-13.48%)
Updated Sep 9, 2024 03:59 PM ET
After-Market: $1.23 +0.01 (0.82%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/29/24 |
---|---|
Current Quarter | -0.57 |
EPS Last Quarter | -0.71 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.22 |
Next Year | -1.56 |
EPS (TTM) | -3.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.60M | 1.99M | 6.55M | 6.36M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 1.60M | 1.99M | 6.55M | 6.36M |
Low Estimate | 1.60M | 1.99M | 6.55M | 6.36M |
Year ago Sales | 1.24M | 1.31M | 4.91M | 6.55M |
Year over Year Growth Est. | 29.03% | 51.91% | 33.32% | -2.90% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.57 | -0.51 | -2.22 | -1.56 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.57 | -0.51 | -2.22 | -1.56 |
High Estimate | -0.57 | -0.51 | -2.22 | -1.56 |
Low Estimate | -0.57 | -0.51 | -2.22 | -1.56 |
Year ago EPS | -1.00 | -0.70 | -4.24 | -2.22 |
Year over Year Growth Est. | 43.00% | 27.14% | 47.64% | 29.73% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.57 | -0.51 | -2.22 | -1.56 |
7 Days Ago | -0.57 | -0.51 | -2.22 | -1.56 |
30 Days Ago | NA | NA | NA | NA |
60 Days Ago | NA | NA | NA | NA |
90 Days Ago | -0.25 | -0.25 | -0.99 | -1.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.51 | -2.22 | -1.56 |
Zacks Consensus Estimate | -0.57 | -0.51 | -2.22 | -1.56 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.71 | -0.75 | -0.70 | -1.00 | NA |
Estimate | NA | NA | -0.78 | -0.58 | NA |
Difference | NA | NA | 0.08 | -0.42 | -0.17 |
Surprise | NA | NA | 10.26% | -72.41% | -31.08% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more